DSIP dosage research typically cites 100-500 mcg per night, but delta sleep-inducing peptide is not FDA-approved for human use. Here's what studies show.
DSIP (delta sleep-inducing peptide) is a nine-amino-acid peptide that scientists have studied since the 1970s for its effects on sleep. The DSIP dosage most often cited in research papers and self-reported protocols is 100 mcg to 500 mcg per day, usually taken in the evening or before bed. DSIP is not FDA-approved for human use in the United States and is sold only as a research chemical.
There is no standard, regulator-endorsed dose. Human trials were small, mostly run decades ago, and used a mix of injection and intranasal routes. The information below summarizes what those studies and current community reports describe. It is not a recommendation or a medical instruction.
Why DSIP Dosing Is Not Standardized
DSIP was first isolated from rabbit brain tissue in 1977. Early human studies in Europe and Japan used intravenous and intranasal delivery, often around 25 to 50 nmol/kg, and results were inconsistent. No large modern trial has ever established an effective human dose.
That gap is why online dosing discussions vary so widely. Someone reading a 1980s study may see one number, while a current forum thread suggests another. Without a regulatory standard, every dose estimate is an extrapolation.
Typical DSIP Dosage Ranges Reported in Research
Most cited amounts fall between 100 mcg and 1 mg per day, with 100 to 500 mcg as the most common window. Timing is almost always in the evening because DSIP is associated with slow-wave sleep.
| Route | Commonly cited amount | Typical timing |
|---|---|---|
| Subcutaneous injection | 100-500 mcg per day | 30-60 minutes before bed |
| Intramuscular injection | 100-500 mcg per day | Evening |
| Intranasal spray | 100-500 mcg total per day | Before bed |
| Intravenous (research only) | 25-50 nmol/kg in older studies | Laboratory settings |
| Oral capsules | 100-500 mcg, absorption is poor | Before bed |
None of these routes is FDA-approved for human use, and none has a validated dosing schedule.
Delta Sleep-Inducing Peptide Dose by Route
Subcutaneous and Intramuscular Injection
Subcutaneous injection is the route most discussed in peptide communities. Anecdotal starting points cluster near 100 mcg, with 250 to 500 mcg reported by people who say lower amounts did nothing for them.
Amounts above 1 mg per day appear rarely and are not supported by published human data.
Intranasal Use
A dsip nasal spray dosage that shows up repeatedly in anecdotal reports is 100 to 300 mcg delivered before bed. Intranasal delivery avoids needles, but absorption varies with spray technique and formulation.
Older clinical work did use intranasal DSIP, which is part of why this route stays popular.
Oral and Other Routes
DSIP is a peptide, so oral capsules are likely broken down by digestive enzymes before reaching the bloodstream. Reported oral amounts therefore tend to sit at the high end of the range, but absorption remains uncertain.
Reconstituting DSIP: 5 mg and 10 mg Vial Math
Most DSIP arrives as a lyophilized powder in a 5 mg or 10 mg vial. You add bacteriostatic water, and the resulting concentration depends only on how much water you use.
| Vial size | Water added | Concentration | Volume for 100 mcg | Volume for 250 mcg |
|---|---|---|---|---|
| 5 mg | 2 mL | 2,500 mcg/mL | 0.04 mL (4 units) | 0.1 mL (10 units) |
| 5 mg | 5 mL | 1,000 mcg/mL | 0.1 mL (10 units) | 0.25 mL (25 units) |
| 10 mg | 2 mL | 5,000 mcg/mL | 0.02 mL (2 units) | 0.05 mL (5 units) |
| 10 mg | 5 mL | 2,000 mcg/mL | 0.05 mL (5 units) | 0.125 mL (12.5 units) |
Anyone comparing a dsip 5mg dosage with a dsip peptide dosage 10mg is really comparing two concentrations of the same peptide. The vial label matters far less than the water volume and the syringe markings.
Always verify the math by hand. A misplaced decimal point turns a 100 mcg dose into a 1,000 mcg dose.
DSIP Dosage Cycle and Timing
No official dsip dosage cycle exists, because DSIP has never been approved for clinical use. Self-reported schedules usually fall into one of a few patterns:
- 5 days on, 2 days off
- 2 to 4 weeks daily, then a 1 to 2 week break
- Every other night, on an ongoing basis
People searching for a dsip dosage for sleep generally time their last dose 30 to 60 minutes before bed. Morning dosing is uncommon because the peptide is linked to sleep onset.
There is no evidence that cycling prevents tolerance or side effects. Anyone asking about DSIP for alcohol or benzodiazepine withdrawal should know that this use rests almost entirely on animal data and early anecdotal reports.
Safety, Side Effects, and Legal Status
DSIP is not FDA-approved for human use in the United States. It is legally sold as a research chemical marked for laboratory use only, which means no regulator has reviewed its purity, sterility, or dosing for people.
Reported side effects in small, older studies include headache, nausea, dizziness, morning grogginess, and temporary drops in blood pressure. Injection-site irritation is also common with subcutaneous use.
Product quality is a genuine concern. Vials sold online vary widely in purity, and a certificate of analysis is not the same as a pharmaceutical guarantee.
Anyone considering DSIP should talk with a licensed healthcare professional first, especially if they take blood pressure medication, sedatives, or antidepressants.
The Bottom Line
The DSIP dosage cited most often in research and online protocols is 100 to 500 mcg per day, taken in the evening. No standard human dose has been established, and DSIP is not approved for human use in the United States.
Because the evidence is thin and products are unregulated, DSIP carries unknown risks. Persistent sleep problems have well-studied, FDA-approved treatments that are worth discussing with a doctor before experimenting with research peptides.
Frequently Asked Questions
What is a typical DSIP dosage for sleep?
Published research and self-reported protocols most often land between 100 mcg and 500 mcg per day, taken 30 to 60 minutes before bed. Some older studies used higher amounts, and no dose has been validated by regulators. DSIP is not FDA-approved for human use, so any number should be treated as experimental.
Is DSIP legal to buy in the United States?
DSIP is not FDA-approved for human use, but it can be sold as a research chemical labeled for laboratory use only. Buying it for personal consumption sits outside that labeling, and importing it for human use may raise regulatory issues. Researchers typically purchase from suppliers that provide a third-party certificate of analysis.
Does DSIP have side effects?
Small, older studies and user reports mention headache, nausea, dizziness, morning grogginess, and mild drops in blood pressure. Injection-site irritation can also occur with subcutaneous use. Because long-term safety data are lacking, anyone with a health condition or taking medication should speak with a healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.